Telacebec treatment for Buruli ulcer in adults
Part of Infections, Skin clinical trials.
This trial tests whether the drug telacebec can treat Buruli ulcer, a skin infection caused by bacteria. It aims to find a simpler, shorter treatment for people with mild to moderate lesions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed Buruli ulcer diagnosed by a doctor, with one or more sores smaller than 4 inches across.
- You must have a positive lab test (PCR or culture) showing the bacteria that causes Buruli ulcer.
- You must be 18 years or older.
- You cannot have had Buruli ulcer treatment in the last year.
- You cannot plan to have surgery to cut out the ulcer during the study (normal wound care is okay).
- If you are 60 or older, you must weigh less than 85 kg (about 187 pounds).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new antibiotic, Contezolid, can quickly reduce the amount of Mycobacterium abscessus in your lungs. It may be a treatment option if you have had a positive sputum test in the past 6 months.
This study tests new combinations of drugs for treating pulmonary tuberculosis (TB). The goal is to find more effective and safer treatments than the current standard.
This trial studies a specific drug combination (BPaLM) for adults with drug-resistant pulmonary (lung) tuberculosis. If you qualify, the goal is to see whether this treatment is effective and safe for your type of infection.
This study tests different ways to treat active lung TB that is not resistant to rifampicin. It aims to find the best treatment duration and combination to cure TB and prevent it from coming back.
This Phase 2 study tests treatment for people with newly diagnosed, drug-susceptible pulmonary (lung) tuberculosis (TB). It aims to see whether the study treatment works well and is safe for curing TB.
This trial compares two medications, telitacicept and belimumab, to see which is safer and more effective for treating lupus. It might help you if standard treatments haven't worked well for you.
Hear when a new Buruli Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.